Table 3.
Correlation analysis of the expression of LncRNA PTGS2 with the clinicopathological features of T2DM
| Variables | LncRNA PTGS2 | P | |
|---|---|---|---|
|
| |||
| High (n=27) | Low (n=18) | ||
| Gender (n) | 0.763 | ||
| Male | 14 | 8 | |
| Female | 13 | 10 | |
| Age (n) | 0.241 | ||
| ≤50 | 10 | 10 | |
| >50 | 17 | 8 | |
| Weight loss (n) | 0.031 | ||
| Yes | 19 | 6 | |
| No | 8 | 12 | |
| Fasting blood glucose (n) | 0.005 | ||
| High | 22 | 7 | |
| Low | 5 | 11 | |
| High blood pressure (n) | 0.365 | ||
| Yes | 12 | 11 | |
| No | 15 | 7 | |
Note: LncRNA: long non-coding RNA; T2DM: Type 2 Diabetes Mellitus. The grouping of fasting blood glucose was sorted according to the fasting blood glucose of each patient from high to low, and divided by the median. The median and above were divided into the hyperglycemia group, and the following was divided into the hypoglycemia group.